Quantum Biopharma (QNTM) Total Current Liabilities (2018 - 2026)
Quantum Biopharma recorded quarterly Total Current Liabilities of $16.3 million in Q1 2026, up 169.81% quarter-over-quarter from $6.1 million in Q4 2025, and up 58.02% year-over-year from $10.3 million in Q1 2025.
Quantum Biopharma's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $16.3 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 58.02% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $16.3 million (up 58.02% YoY), while the FY2025 annual figure was $6.1 million, down 9.29% from the prior year.
- Total Current Liabilities came in at $16.3 million for Q1 2026 at Quantum Biopharma, up from $6.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $16.3 million in Q1 2026 to a low of $4.6 million in Q4 2023.
- A 5-year average of $8.5 million and a median of $6.7 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities tumbled 41.69% in 2023 and surged 162.64% in 2025, its largest moves.
- Quantum Biopharma's Total Current Liabilities stood at $7.8 million in 2022, then slumped by 41.69% to $4.6 million in 2023, then jumped by 46.29% to $6.7 million in 2024, then slipped by 9.29% to $6.1 million in 2025, then jumped by 169.81% to $16.3 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $16.3 million, $6.1 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 289.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.35 Mn |
| Dec 31, 2025 | 6.06 Mn |
| Sep 30, 2025 | 6.65 Mn |
| Jun 30, 2025 | 13.25 Mn |
| Mar 31, 2025 | 10.34 Mn |
| Dec 31, 2024 | 6.68 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Dec 31, 2023 | 4.57 Mn |
| Dec 31, 2022 | 7.83 Mn |
| Dec 31, 2021 | 8.70 Mn |
| Dec 31, 2020 | 5.58 Mn |
| Dec 31, 2019 | 6.88 Mn |
| Dec 31, 2018 | 1.32 Mn |